MarketsSingle-source
2.0
Kymera Therapeutics files 8-K regarding executive and director changes
SEC EDGAR 8-K FilingsLO·US·about 9 hours ago
SPX Technologies has filed an 8-K form disclosing a change in corporate leadership or compensatory arrangements under Item 5.02. The specific identity of the departing individual and the impact on company strategy remain unconfirmed pending further disclosure.
Entities